Dr. Reddy's Eyes Big Growth in India

Hey, did you hear about Dr. Reddy's latest performance? They just reported better-than-expected Q1 results and are targeting double-digit revenue growth in India for FY25. They've been really busy, launching 13 new brands and leveraging Sanofi India's vaccine portfolio, which boosted their domestic revenue by 15%. 

With sales hitting ₹1,330 crore in Q1, they’re now the 10th largest player in the Indian market. The management is super committed to growing in India and is even looking at potential acquisitions to fuel this growth. Sounds like they're on a solid path!